PerkinElmer to Present Translating Data into Clinical Medicine at the Bio-IT
Bio-IT World Conference & Expo 2013
WALTHAM, Mass. -- April 05, 2013
PerkinElmer, Inc. (NYSE:PKI), a global leader focused on improving the health
and safety of people and the environment, today announced that the Company
will present at the Bio-IT World Conference at 11:00AM eastern time on
Wednesday, April 10, 2013 at the Seaport World Trade Center located at 200
Seaport Boulevard in Boston, MA.
Kevin Hrusovsky, president of PerkinElmer’s Life Sciences &Technology
business, will be a featured speaker at the Bio-IT World Conference’s Cancer
Informatics track. In his Tools for Revolutionizing Translational Cancer
Medicine presentation, Mr. Hrusovsky will discuss how combining the “in
vitro-to-in vivo-to human” continuum of research tools with a powerful
informatics platform may successfully bridge the chasm from laboratory
research to clinical applications, particularly in the field of cancer
medicine and personalized health.
For more information, visit the Bio-IT World Conference website.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The company reported revenue of
approximately $2.1 billion in 2012, has about 7,500 employees serving
customers in more than 150 countries, and is a component of the S&P 500 Index.
Additional information is available through 1-877-PKI-NYSE, or at
Edelman (on behalf of PerkinElmer)
Paul Barren, 404-460-9679
Press spacebar to pause and continue. Press esc to stop.